Day 1
Sunday 21 May
OPENING CEREMONY
- Welcome addresses
- Awards Ceremony
- Opening Lecture
Forgiveness for Individual, Family, and Community Well-Being
R. Enright (USA) - Welcome Cocktail
Day 2
Monday 22 May
- 9:00 – 11:00 EFLM SYMPOSIUM
Inappropriate use of laboratory resources – Demand management tools and how to use them – Session chairs: J. Cadamuro (Austria), M. Salinas (Spain)
Definition and magnitude of over-and underuse – J. Cadamuro (Austria)
Tools to overcome inappropriate test ordering – A. von Meyer (Germany)
Examples of successful interventions – M. Salinas (Spain)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 IFCC SYMPOSIUM
Artificial intelligence applications in clinical laboratory medicine – Session chair: D. Gruson (Belgium)
Artificial intelligence: current and future applications in laboratory medicine – D. Gruson (Belgium)
The Ethics of Point of Care Devices and the Need for AI Policy Frameworks in Resources Limited Settings – M. Gmira (Morocco)
The value of AI in the mobile health ecosystem – N. Delvaux (Belgium)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 IFCC SYMPOSIUM
Precision Medicine will boost Medical Test Standardization of Protein Biomarkers – Session chairs: C. Cobbaert (Netherlands), P. Gillery (France)
Critical Appraisal of IFCC SD standardization/harmonization efforts: making up the balance – P. Gillery (France)
Embracing (patho-)physiological diversity at the molecular level: unraveling the human blood proteome – N. Kelleher (USA)
Promising (glyco-)proteoform measuring technologies to accurately quantify the measurand of interest: what is in the pipeline? – Y. van der Burgt (Netherlands)
Bottom-up proteomics enables peptide-based calibration of molecular defined proteins for realizing SI-traceability of test results – C. Cobbaert (Netherlands)
Credits: 2 CPECS® - 9:00 – 11:00 SYMPOSIUM 1
MicroRNA: from detection technologies to applications – Session chair: V. Taly (France)
EV associated Biomarkers in Liquid Biopsies — How to identify valid microRNA Biomarker Signatures in circulating extracellular vesicles – M. W. Pfaffl (Germany)
Droplet-based microfluidics for miRNA detection – V. Taly (France)
miRNA profiling in cells and extra-cellular vesicles using high-throughput sequencing in human diseases and disease models – J. Tost (France)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11.00 EFLM SYMPOSIUM
Precision Medicine – Session chair: T. Ozben (Turkey)
Multi-omics profiling in the era of cancer Precision Medicine – T. Ozben (Turkey)
Genetic diagnosis and multi-omics clustering for diabetes precision medicine – P. Froguel (UK)
Computer-assisted integration of multi-dimensional patient’s data for poly-therapies management – M. Simmaco (Italy)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 SIBioC SYMPOSIUM
Opportunities and challenges for digital morphology in Hematology – Session Chairs: S. Buoro (Italy), G. Da Rin (Italy)
From the digital microscope to artificial intelligence – G. D’Onofrio (Italy)
The virtual slide in hematology – G. Zini (Italy)
Digital morphology analyzers in hematology: a disruptive innovation? The experience of SIBioC hematology study group – M. Seghezzi (Italy)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 11:30 – 12:30 PLENARY LECTURE
Digital health, big data and smart technologies for the care of patients with cancer – N. Waddel (Australia)
Credit: 1 CPECS® - 12:30 – 14:00 POSTER SESSION
- 14:30 – 16:30 IFCC SYMPOSIUM
Central Role of the Clinical Laboratory in Public Health & Patient Care Continuum – Session chairs: R. Erasmus (South Africa), A. St John (Australia)
Critical review of the evidence supporting the value of laboratory medicine in clinical care – K. Adeli (Canada)
Anatomy of a value proposition for laboratory medicine – A. St John (Australia)
Demonstrating the value of laboratory medicine from an industry perspective – B. Meyer (UK)
Strategies for Promoting the Value of Laboratory Medicine in North America – D. Kinniburgh (Canada)
Credits: 2 CPECS® - 14:30 – 15:30 MEET THE EXPERT
Infrared spectroscopy – S. De Bruyne (Belgium)
Credits: 2 CPECS® - 15:45 – 16:45 DEBATE
The use of cardiac biomarkers in risk stratification – F. Apple (USA), N. Mills (UK)
Credits: 2 CPECS® - 16:30-18:00 Special Session
Machine Learning in Laboratory Medicine: Recommendations from the IFCC Working Group & Case Studies – Chair N. Rifai (USA)
Speakers:
S. Master (USA), T. Badrick (Australia), S. Haymond (USA), A. Bietenbeck (Germany)
Credits: 1,5 CPECS®
Day 3
Tuesday 23 May
- 9:00 – 11:00 SYMPOSIUM 2
COVID-19 diagnosis, therapy and outcome – Session chair: M. Ciccozzi (Italy)
SARS-CoV-2: Epidemiological and genomic analysis – L.B. Snell (UK)
Challenges in COVID-19 testing strategies – P. M Bossuyt (Netherlands)
Severe COVID-19: is it a viral or an immunological disease? – A. Guillon (France)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 SYMPOSIUM 3
Diagnostic Challenges in Sepsis – Session chair: C. Tsatsanis (Greece)
Immunology of sepsis: diagnostic and therapeutic challenges– T. Van der Poll (Netherlands)
Harmonisation of Procalcitonin as a sepsis biomarker: problems and solutions – V. Delatour (France)
Functional biomarkers of Sepsis Immunosuppression – C. Tsatsanis (Greece)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 SYMPOSIUM 4
Towards the next generation of Laboratory Information Systems – Session chair: V. Lukić (Serbia)
LIS 2.0: what does the future hold? – V. Lukić (Serbia)
Are laboratory information systems prepared for interconnected health care? – A. Bietenbeck (Germany)
An evaluation framework for effective and safe laboratory information systems – M. Yusof (Malaysia)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9.00 – 11.00 SYMPOSIUM 5
Autoimmune diseases – Session chairs: D. Barnali (India), J. Sheldon (UK)
IgG4 related disease – E. Della Torre (Italy)
The role of complement in autoimmune disease – J. Thurman (USA) Harmonisation of Autoimmune Testing – J. Sheldon (UK)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 IFCC SYMPOSIUM
Advancing Excellence in Laboratory Medicine Worldwide: An Update from IFCC
Taskforces – Session chairs: K. Adeli (Canada), A. Haliassos (Greece)
Enhancing Laboratory Quality on a Global Level: Results of the IFCC EQA Pilot Study – E. Amann (Germany)
Closing the Gaps in Newborn Screening: The IFCC Global NBS Program – J. Bonham (UK)
Impact of the Clinical Laboratory in Clinical Medicine: Developing the Evidence – Z. Zhan (USA)
Global Database of Adult and Pediatric Reference Intervals – J. Zierk (Germany)
Credits: 2 CPECS® - 9:00 – 11:00 SIBIOC SYMPOSIUM
The challenge of harmonization in laboratory medicine – Session chairs: A. Carobene (Italy), F. Ceriotti (Italy)
Harmonization of the Pre-analytical phase – A-M. Simundic (Croatia)
Harmonization of the Analytical phase – M. Panteghini (Italy)
Harmonization of the Post-analytical phase – M. Plebani (Italy)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 11:30 – 12:30 PLENARY LECTURE
Viral Evolution and Host Immune Responses – A. Fischer (France)
Credit: 1 CPECS® - 12:30 – 14:00 POSTER SESSION
- 14:30 – 16:30 EFLM SYMPOSIUM
Quality in clinical laboratory: a moving target
Evaluation and monitoring of analytical quality – M. Panteghini (Italy)
Quality indicators in the total testing process – V. De Guire (Canada)
Outcome measurement and integration of quality measures in laboratory medicine – M. Plebani (Italy)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 14:30 – 15:30 PREANALYTICAL CASES
Preanalytical mysteries – S. Jovičić (Serbia), J. Cadamuro (Austria)
Credits: 2 CPECS® - 15:45 – 16:45 CLINICAL CASES
Bone turnover markers + vitamin D – E. Cavallier (Belgium), M. Hermann (Germany)
Credits: 2 CPECS®
Day 4
Wednesday 24 May
- 9:00 – 11:00 SYMPOSIUM 6
Preanalytical phase and patient outcome – Session chair: A.M. Simundic (Croatia)
How to measure patient related outcomes & cost of preanalytical errors? – G. Lippi (Italy)
New venous catheter blood draw device and its impact on patient and laboratory related outcomes – K. Doyle (USA)
Over-estimation of plasma glucose in collection tubes containing citrate stabilizer – C.M. Florkowski (New Zealand)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 SYMPOSIUM 7
Young Scientist Session – Session chairs: K. Taha Ucar (Turkey), B. Das (India)
Circulating cancer biomarkers: where are we now? – A. Tikhonov (Russia)
Immature platelet fraction as an early inflammatory biomarker – C. Imperiali (Spain)
Dialogue between lab and clinicians for a win-win collaboration – M. Lenski (France)
Setting Reference Intervals for analytes with dynamic physiological changes – U. Senarathne (Sri Lanka)
Credits: 2 CPECS® - 9:00 – 11:00 SYMPOSIUM 8
Bone as an endocrine organ – Session chair: E. Cavalier (Belgium)
Relation between bone and energy metabolisms – C. Confavreux (France)
Sclerostin: from pathophysiology to laboratory determination – R. N. Jørgensen (Denmark)
FGF23: clinical and laboratory perspectives – A. Heijboer (Netherlands)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 SYMPOSIUM 9
Translating biomarkers from research to clinical use in traumatic brain injury – Session chairs: K. Makris (Greece), J. Montaner (Spain)
Pathophysiology and epidemiology of traumatic brain injury – J. Montaner (Spain)
Biomarkers of traumatic brain injury: current state and unresolved issues – H. Zettenberg (Sweden)
Neurovascular Unit-Derived Extracellular Vesicles: From Their Physiopathological Roles to Their Clinical Applications in Traumatic Brain Injury – J. C. Sanchez (Switzerland)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 SIBioC SYMPOSIUM
The latest advances in diabetes clinical and laboratory research – Session chairs: A. Mosca (Italy), A. Terreni (Italy)
Nature of diabetes: time for a rethink? – D. Leslie (UK)
Diabetic kidney disease: new clinical and therapeutic issues – G. Pugliese (Italy)
Role of glycated albumin for diagnosis and management of diabetes mellitus – E. Selvin (USA)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 11:30 – 12:30 PLENARY LECTURE
Multi-Omics for Biomarker Discovery: the Value of NMR-Spectroscopy – M. Nauck (Germany)
Credit: 1 CPECS® - 12:30 – 14:00 POSTER SESSION
- 14:30 – 16:30 EQALM SYMPOSIUM
Insights into SARS-CoV-2 associated analytics that only EQA schemes can provide – Session chairs: G.M. Henriksen (Denmark), C. Buchta (Austria)
EQA for SARS-CoV-2 antigen detection – Sensitivity of tests and the potential impact of circulating SARS-CoV-2 variants – O. Donoso Mantke (Germany)
Harmonization of SARS-CoV-2 qPCR results by conversion of Ct values to an international unit system – C. Buchta (Austria)
Insights into analytical method performance by combining data from various EQA providers – Examples from SARS-CoV-2 diagnostics and point-of-care/near patient testing systems – W. Coucke (Belgium)
Results of SARS-CoV-2 antibody determination – a mess or just biology? – H. Zeichhardt (Germany)
Credits: 2 CPECS® - 14:30 – 15:30 CLINICAL CASES
Challenges in the interpretation of laboratory tests in hemostasis – E. Favaloro (Australia)
Credits: 2 CPECS® - 15:45 – 16:45 CLINICAL CASES
Clinical cases: Neuroimmune diseases – Session Chair: J.A. Goodfellow (UK)
“Brain on Fire”: Neuroimmunology Case Study Based Discussion – B. Das (India)
Technical laboratory and clinical challenges and opportunities around autoantibody testing in Neuroimmunology – J.A. Goodfellow (UK)
Credits: 2 CPECS®
Day 5
Thursday 25 May
- 9:00 – 11:00 SYMPOSIUM 10
Biomarkers of liver diseases
Do we need separate non-invasive test to assess nonalcoholic steatohepatitis for patients with and without Human Immunodeficiency Virus? – M. Lemoine (UK)
What combination of non-invasive fibrosis tests should be used for the diagnosis of fibrosis in NAFLD / MAFLD? – J. Boursier (France)
Adipocytokines and liver diseases in 2023: where are we? – C. Peralta (Spain)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 SYMPOSIUM 11
The role of clinical laboratory in kidney transplantation – Session chairs: J. P. Cristol (France), A. Djamali (USA)
Non-invasive biomarkers of kidney allograft injury: role of multimodality testing – A. Djamali (USA)
Immunosuppressive drug Monitoring for a Personalized Therapy – P. Marquet (France)
Kidney functions after transplantation: more than glomerular filtration rate – J. P. Cristol (France)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 SYMPOSIUM 12
Sources of interference in laboratory testing – Session chair: G. Dimeski (Australia)
Biotin interference in laboratory testing – P. B. Kyle (USA)
Troponin Interferences with current generation assays – G. Dimeski (Australia)
Interferences in Immunoassays – K. Ghazal (France)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 SYMPOSIUM 13
Prenatal testing – Session chair: G. Novelli (Italy)
First trimester Fetal Chromosomal Anomaly Screening – G. Novelli (Italy)
EQA in prenatal testing and PAPP-A standardisation – C. Sturgeon (UK)
Risk assessment for pre-eclamsia throughout pregnancy – L. Poon (Hong Kong)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 9:00 – 11:00 SIBioC SYMPOSIUM
Diagnostic workup of monoclonal gammopathies – Session chairs: M. Mussap (Italy), G. Palladini (Italy)
Advances in monitoring and treatment of multiple myeloma – F. Gay (Italy)
Differential diagnosis of MGCS – A. Dispenzieri (USA)
Circulating tumor cells and minimal residual disease in multiple myeloma – B. Paiva (Spain)
Two oral communications selected among participants’ abstracts
Credits: 2 CPECS® - 11.30 – 12.30 PLENARY LECTURE
Diagnostic advances in dementia – K. Blennow (Sweden)
Credit: 1 CPECS® - 12.30 – 13.30 CLOSING CEREMONY
Closing remarks
Congress President – S. Bernardini
IFCC President – K. Adeli
EFLM President – T. Ozben
SIBioC President – T. Trenti
Farewell Cocktail